Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Medplus Health shares rose as much as 11.3% after Q4FY26 profit grew to ₹63.97 crore and revenue increased 23.5% year-on-year to ₹1,864.39 crore.
Apollo Hospitals outlined a multi-year capacity build-out, linking new bed additions, phased commissioning timelines, and capex plans to mid-teen revenue growth and stable margins.
Embassy Developments reported a consolidated net loss of ₹323.78 crore in the March 2026 quarter as revenue fell 61.47%, while FY26 swung to a ₹872.65 crore loss.
Man Industries (India) has completed its all-cash purchase of Saudi pipe maker NPC for about ₹981 crore, adding 4.3 lakh tonnes capacity and expanding Middle East operations.
Hindustan Copper outlined a ₹2,000 crore capex plan to nearly triple ore capacity to 12.2 MTPA by FY31, pushing shares up 14% and guiding steady margins.
Hospital stocks have re-rated since 2019 as operating margins rose from 14% to 22% in FY24, supported by bed shortages, insurance uptake and medical tourism.
Embassy Developments swung to a consolidated loss in Q4 FY26 as revenue dropped sharply, pushing FY26 into the red versus a profit in FY25.
India’s WPI inflation rose to 8.3% in April 2026, led by fuel and power at 24.7%, widening the gap with CPI at 3.48% and raising pass-through concerns.
RBI’s May 22 board meeting could clear a near-record surplus transfer, with economist estimates clustered around Rs 270,000-340,000 crore and direct implications for budget arithmetic.
Adani Group’s defence arm moved to acquire a significant stake in Alpha Design Technologies in a Rs 400 crore deal, adding aerospace structures, avionics and export-linked programmes.
Ola Electric’s Q4 FY26 showed improved gross margin and positive operating cash flow, but revenue fell 56.6% YoY, keeping brokers cautious with ‘Sell’ calls.
Honeywell Automation India shares rallied after Q4 FY26 profit rose 14% year-on-year, EBITDA expanded, and the board recommended a Rs 110 per share final dividend for FY26.
NTPC reported higher Q4 FY25 profit and income, recommended a final dividend for FY25, and later declared a separate Rs 2.75 dividend on 06 Feb 2026.
Gland Pharma signed a share purchase agreement to acquire 100% of Europe-based Cenexi Group, moving ahead on a November 2022 put option framework valued up to €120 million.
WeWork India posted strong Q4 FY26 growth in revenue, EBITDA and profit, sending the stock to an upper circuit as investors focused on FY27 guidance.
Samvardhana Motherson has reiterated its Vision 2030 plan to reach $108 billion gross revenue, backed by FY26 revenue of $22.9 billion and net debt-to-EBITDA leverage of 1.1x.